Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biogen
biotech
boston blog main
2
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
ptc therapeutics
startups
2
×
venture capital
2
×
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
antisense oligonucleotide
asklepios biopharmaceutical
benzodiazepines
bioeurope
biomarin pharmaceutical
blackstone group
blackstone life sciences
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
clinical trials
columbia university
david goldstein
deerfield management
depression
detroit blog main
detroit top stories
drug development
drug discovery
epi4k
What
medicines
2
×
new
2
×
activity
aims
approvals
backed
bio
biogen
cause
ceo
clamped
covid
delays
developing
drugs
economic
epilepsy
fast
fda
genes
genetic
including
ipo
isn’t
links
lot
marcio
mutations
neuro
oric’s
praxis
precision
research
roundup
showing
souza
spread
stop
testing
turn
Language
unset
Current search:
new
×
startups
×
photo
×
medicines
×
" boston blog main "
×
" venture capital "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More